Mapping an ELSI-integrated translational pathway with cell-free fetal DNA testing

通过无细胞胎儿 DNA 测试绘制 ELSI 整合翻译途径

基本信息

项目摘要

PROJECT SUMMARY/ABSTRACT The objective of this training and research project is to develop the candidate into an independent and interdisciplinary ELSI researcher, with the ability to intertwine qualitative empirical with normative approaches to issues in genetics and genomics. To accomplish this objective, I have proposed: (1) Training that builds upon my previous education and experience as a qualitative social scientist with additional training in genetics and bioethics; and (2) Research that takes a combined social scientific and bioethical approach to understanding and guiding the translational pathways of new genetic innovations. The proposed training includes coursework, directed readings, seminars and workshops, and the mentored development of an interdisciplinary ELSI research project. The long-term goal of the research project is to map out an ELSI-integrated translational pathway for genetic innovations: building a model of crucial points for, and types of, ELSI guidance throughout these translational processes. The specific Aims of this project are: (1) To follow the unfolding translational pathway of cffDNA testing technology, as a case study in translation processes for genetic innovations; and (2) To map crucial points for ELSI guidance along the translational pathway of genetic innovations. Through individual interviews with stakeholders and observations of meetings and conferences of stakeholders, this mapping project will examine the case of cell-free fetal DNA (cffDNA) testing and the actors and networks that influence its development toward potential clinical applications. Comparing features of this process with those of other translations of genetic innovations, it will identify critical moments, turning points, and intersections at which important decisions shape the unfolding translational pathway. Finally, through collaboration with key stakeholders in cffDNA and non-invasive prenatal testing, a model will be developed that proposes types of ethical and social guidance for these crucial points that would likely be most beneficial.
项目总结/摘要 该培训和研究项目的目标是将候选人发展成为一个独立的, 跨学科的ELSI研究人员,具有将定性经验与规范方法相结合的能力 遗传学和基因组学的问题。为了实现这一目标,我建议:(1)建立 根据我以前的教育和经验,作为一个定性的社会科学家,在遗传学方面的额外培训 (2)采取社会科学和生物伦理相结合的方法进行的研究, 理解和指导新基因创新的转化途径。拟议的培训 包括课程作业、指导性阅读、研讨会和讲习班,以及 跨学科ELSI研究项目。 该研究项目的长期目标是绘制出一个ELSI整合的遗传转化途径, 创新:建立一个模型的关键点,和类型,ELSI的指导,在这些翻译 流程.本课题的具体目的是:(1)研究cffDNA的解折叠翻译途径 测试技术,作为遗传创新翻译过程的案例研究;(2)映射关键 点ELSI指导沿着转化途径的遗传创新。通过个别访谈 与利益攸关方和利益攸关方会议的意见,这一绘图项目将 检查无细胞胎儿DNA(cffDNA)测试的情况下,影响其行为者和网络 向潜在的临床应用发展。将该过程的特征与其他过程的特征进行比较, 基因创新的翻译,它将确定关键时刻,转折点,和交叉点, 重要的决定塑造了展开的翻译途径。最后,通过与关键 cffDNA和非侵入性产前检测的利益相关者,将开发一个模型,提出各种类型的 道德和社会指导这些关键点,可能是最有益的。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Marsha Mabry Michie其他文献

Marsha Mabry Michie的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Marsha Mabry Michie', 18)}}的其他基金

Prenatal Preparation: Actions and Results
产前准备:行动和结果
  • 批准号:
    10183280
  • 财政年份:
    2019
  • 资助金额:
    $ 24.89万
  • 项目类别:
Prenatal Preparation: Actions and Results
产前准备:行动和结果
  • 批准号:
    10438812
  • 财政年份:
    2019
  • 资助金额:
    $ 24.89万
  • 项目类别:
Prenatal Preparation: Actions and Results
产前准备:行动和结果
  • 批准号:
    10017283
  • 财政年份:
    2019
  • 资助金额:
    $ 24.89万
  • 项目类别:
Mapping an ELSI-integrated translational pathway with cell-free fetal DNA testing
通过无细胞胎儿 DNA 测试绘制 ELSI 整合翻译途径
  • 批准号:
    9069463
  • 财政年份:
    2014
  • 资助金额:
    $ 24.89万
  • 项目类别:
Mapping an ELSI-integrated translational pathway with cell-free fetal DNA testing
通过无细胞胎儿 DNA 测试绘制 ELSI 整合翻译途径
  • 批准号:
    8225444
  • 财政年份:
    2012
  • 资助金额:
    $ 24.89万
  • 项目类别:
Mapping an ELSI-integrated translational pathway with cell-free fetal DNA testing
通过无细胞胎儿 DNA 测试绘制 ELSI 整合翻译途径
  • 批准号:
    8460833
  • 财政年份:
    2012
  • 资助金额:
    $ 24.89万
  • 项目类别:

相似海外基金

Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
  • 批准号:
    24K16436
  • 财政年份:
    2024
  • 资助金额:
    $ 24.89万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
  • 批准号:
    10093543
  • 财政年份:
    2024
  • 资助金额:
    $ 24.89万
  • 项目类别:
    Collaborative R&D
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
  • 批准号:
    24K16488
  • 财政年份:
    2024
  • 资助金额:
    $ 24.89万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 24.89万
  • 项目类别:
    EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
  • 批准号:
    24K20973
  • 财政年份:
    2024
  • 资助金额:
    $ 24.89万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 24.89万
  • 项目类别:
    EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
  • 批准号:
    481560
  • 财政年份:
    2023
  • 资助金额:
    $ 24.89万
  • 项目类别:
    Operating Grants
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
  • 批准号:
    10075502
  • 财政年份:
    2023
  • 资助金额:
    $ 24.89万
  • 项目类别:
    Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
  • 批准号:
    10089082
  • 财政年份:
    2023
  • 资助金额:
    $ 24.89万
  • 项目类别:
    EU-Funded
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
  • 批准号:
    2321091
  • 财政年份:
    2023
  • 资助金额:
    $ 24.89万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了